Figure 1.
PaccMann framework for multimodal prediction of IC50 drug sensitivity. Three key data modalities that influence anticancer drug sensitivity are integrated: biomolecular measurements of cancer cells, e.g. gene expression data, a network of known interactions between the biomolecular entities and the chemical structure of the anticancer compounds (SMILES strings or molecular fingerprints).